HIBAPRESS – MAP
The company "IM MEDICARE" inaugurated today, Friday, in the Sidi Bou Othman industrial complex (Rehamna Province), its new industrial unit for the production of subcutaneous injections and vaccination injections.
The opening ceremony of this unit was chaired by the Minister of Industry and Trade, Ryad Mezzour, in the presence of, in particular, the Governor of Rehamna Province, Aziz Bouinyan. This project, which was implemented with an investment of 85 million dirhams, will create 70 direct jobs, and the annual production capacity will reach 450 million injections, aimed at meeting the needs of the national market and supporting the Kingdom's destination towards African markets. This project also responds to the national priority of strengthening sovereignty in the medical devices sector, and also contributes to the socio-economic development of the Marrakesh-Safi region, by creating qualified jobs and supporting the role of local companies in the dynamics of the regional industry. In a speech on the occasion, Mezzour highlighted that this project embodies the ability of Moroccan companies to innovate and produce with excellence, and to prove themselves as a reliable and recognized supplier in the global market for vaccination products. He added that “this industrial unit symbolizes the completion of an ambitious vision that seeks to strengthen Morocco’s position in strategic specializations with high added value, thus contributing to the development of the “Made in Morocco” brand in this sector, and in the competitive compensation of imports, in addition to strengthening the health sovereignty of our country.” For his part, the CEO of "IM MEDICARE", Mohamed Idrissi Kaitouni, confirmed that this new industrial unit constitutes an important stage in the company's development, by strengthening its production capabilities of subcutaneous injections and vaccination injections, while meeting the requirements of quality and safety in accordance with international standards. He added that this project falls within the context of the dynamics of the national medical devices sector, whose indicators are recording continuous growth, with 1,378 jobs, 376 million dirhams in investments, a turnover of 903 million dirhams, and a value-added rate of 46 percent, which reflects the rapid doubling of investment, activities, and wealth generated over the past twenty-five years. He pointed out that “this project reflects the company’s commitment to contributing to national health sovereignty, meeting the needs of the local market, and keeping pace with the Kingdom’s opening to African markets, through competitive production and high added value.”
